“…Polymorphic phase transition, defined as a transition of a crystalline phase at a certain temperature and pressure to another crystalline phase of the same composition with different crystal structures, is a critical phenomenon in the field of pharmaceutical chemistry because the different physical properties of polymorphs such as bioavailability and solubility also have intellectual property rights. , Crystal structures with a large number of molecules in the asymmetric unit ( Z ′), i.e., high- Z ′, are not only a scientific curiosity but also attract many scientists as an informative subset of crystal structures to understand crystallization and polymorphism. − Indeed, the new crystal structure of a simple compound, the hydrochloride salt of fampridine, where Z ′ = 30, was recently reported as a Frank–Kasper (FK) phase, and this class of materials is expected to open new perspectives in the field of supramolecular chemistry and material science . Peptide compounds, which have recently attracted attention as building blocks of porous materials , and are being developed for use as a promising class of molecular pharmaceutics, − have been reported to exhibit many polymorphs due to the conformational flexibility derived from the side chain structure of amino acids.…”